Glycopyrrolate in pharma franchise in Manipur

Glycopyrrolate in PCD pharma franchise in Imphal

Glycopyrrolate in top pharma company in Kalyan-Dombivli

Glycopyrrolate pcd pharma supplier in Vasai-Virar

Glycopyrrolate in phama franchise company in India
Glycopyrrolate in phama distributor in Varanasi

Home/Products /glycopyrrolate-25mcg-respule

Glycopryl 25 Respule

Composition : Glycopyrrolate (25mcg) Respule

Dosage Form : Respule

Packaging Type : Pack

Packaging : 4*5*2ml

Price : ₹350/-

Glycopryl 25 Respule is a prescription medication containing Glycopyrrolate, a long-acting anticholinergic agent used primarily in the treatment of respiratory conditions. Glycopyrrolate works by blocking the action of acetylcholine, a neurotransmitter that stimulates the contraction of smooth muscles in the lungs. By inhibiting acetylcholine, Glycopryl helps to relax the muscles around the airways, resulting in improved airflow and easier breathing.

This medication is commonly used in the management of chronic obstructive pulmonary disease (COPD) and can be used in combination with other respiratory treatments to improve lung function. Glycopryl 25 Respule is intended for use with a nebulizer, which transforms the liquid solution into a fine mist, allowing it to be inhaled directly into the lungs. This ensures rapid and efficient delivery of the medication to the airways.

Glycopryl 25 Respule is beneficial for those experiencing persistent airway constriction and helps to reduce the frequency of exacerbations associated with COPD. It can also be used for other conditions as directed by a healthcare provider.

Read More

About the Product

Glycopryl 25 Respule is a prescription medication containing Glycopyrrolate, a long-acting anticholinergic agent used primarily in the treatment of respiratory conditions. Glycopyrrolate works by blocking the action of acetylcholine, a neurotransmitter that stimulates the contraction of smooth muscles in the lungs. By inhibiting acetylcholine, Glycopryl helps to relax the muscles around the airways, resulting in improved airflow and easier breathing.

This medication is commonly used in the management of chronic obstructive pulmonary disease (COPD) and can be used in combination with other respiratory treatments to improve lung function. Glycopryl 25 Respule is intended for use with a nebulizer, which transforms the liquid solution into a fine mist, allowing it to be inhaled directly into the lungs. This ensures rapid and efficient delivery of the medication to the airways.

Glycopryl 25 Respule is beneficial for those experiencing persistent airway constriction and helps to reduce the frequency of exacerbations associated with COPD. It can also be used for other conditions as directed by a healthcare provider.

Possible side effects include dry mouth, sore throat, cough, or a mild headache. In rare cases, it may cause blurred vision or urinary retention.

Glycopryl 25 Respule is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) and for reducing bronchospasm in respiratory conditions.

Not for use during acute asthma attacks. Follow the prescribed dosage and consult a healthcare provider if symptoms persist.

Store at room temperature, away from moisture, heat, and sunlight. Keep the vial tightly closed and out of the reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation